Skip to content
Back to skills

Enda Avoid Long Acting Glucocorticoids Children

ASecurity

Suggests avoiding synthetic, long-acting glucocorticoids (e.g., prednisolone, dexamethasone) in children with primary adrenal insufficiency (PAI). Use when selecting glucocorticoid replacement for a child with PAI to prevent Cushingoid side effects and dose titration difficulties.

  • 12 stars
  • 0 votes
  • 0 copies
  • 3 views
  • Added September 9, 2026
ai-agentsgorails

Works with

  • cli

Security analysis

A100/100

Scanned September 9, 2026

npx -y skills add dromlakhani/MD2SKILL --skill enda-avoid-long-acting-glucocorticoids-children --agent claude-code

Installs into .claude/skills of the current project.

Are you the author of Enda Avoid Long Acting Glucocorticoids Children?

Add the live security badge to your README. It updates with every re-scan.

Security grade badge for Enda Avoid Long Acting Glucocorticoids Children
[![Security: A — Skills Directory](https://www.skillsdirectory.com/api/skills/dromlakhani-enda-avoid-long-acting-glucocorticoids-children/badge)](https://www.skillsdirectory.com/skills/dromlakhani-enda-avoid-long-acting-glucocorticoids-children)

More formats (shields.io, HTML) on the badges page. Keep it an A: scan every change in CI with Pro.

Download with Pro
SKILL.md
---
name: enda-avoid-long-acting-glucocorticoids-children
description: Suggests avoiding synthetic, long-acting glucocorticoids (e.g., prednisolone, dexamethasone) in children with primary adrenal insufficiency (PAI). Use when selecting glucocorticoid replacement for a child with PAI to prevent Cushingoid side effects and dose titration difficulties.
---

# Avoid Synthetic, Long-Acting Glucocorticoids in Children with PAI

## STEP 1 — Gather Information
Confirm diagnosis of PAI in the child (via ACTH stimulation test or clinical/lab criteria) and assess need for glucocorticoid replacement therapy.

## STEP 2 — Rule In / Rule Out
If the child has PAI and requires glucocorticoid replacement, rule out synthetic, long-acting glucocorticoids (prednisolone, dexamethasone) due to risks in pediatric PAI.

## STEP 3 — Classify or Stratify
Classify glucocorticoid options: preferred short-acting agents (hydrocortisone, cortisone acetate) versus avoided long-acting agents (prednisolone, dexamethasone).

## STEP 4 — Decide
Initiate glucocorticoid replacement with hydrocortisone (8 mg/m²/day in three or four divided doses) or cortisone acetate (20–35 mg/day in two or three divided doses); avoid prednisolone and dexamethasone entirely.

## Clinical Guardrails / Mimics / Pitfalls
Do not use dexamethasone due to high risk of Cushingoid side effects and difficulty in dose titration. Avoid prednisolone in children with PAI as it is long-acting and may cause overexposure; if hydrocortisone is unavailable, prednisolone is a last-resort alternative only with extreme caution (per guideline 3.3), but dexamethasone remains least preferred.

## Concrete Clinical Example
A 6-year-old girl with PAI (autoimmune etiology) is started on hydrocortisone 9 mg/m²/day in three divided doses (5 mg/m² morning, 2 mg/m² noon, 2 mg/m² evening) after confirming low cortisol and high ACTH. Prednisolone and dexamethasone are avoided per guideline 3.19.

**Source:** Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI: 10.1210/jc.2015-1710

Attribution

Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.

Comments

Loading comments…